Tara Lech, PharmD @anticoagpharmd.bsky.social · 03/12/2025Excited to share this article highlighting the important role of Antithrombosis Stewardship to improve Safe Transitions of Care in pts with VTE. #Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare @jthjournal.bsky.social @isth.org www.sciencedirect.com:5037/science/arti...sciencedirect.com 032
Reposted by Tara Lech, PharmDInternational Society on Thrombosis and Haemostasis @isth.org · 06/08/2025📢📢NEW research from @jthjournal.bsky.social! Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af 1105
Tara Lech, PharmD @anticoagpharmd.bsky.social · 07/07/2025Who would have thought VTE management could be so much fun! Thank you @thecurbsiders.bsky.social 🫶🏼 #PharmSky #MedSky #CardioSky #SkyRx #HemeSky @anticoagforum.bsky.social 141
Tara Lech, PharmD @anticoagpharmd.bsky.social · 27/06/2025💥If you want to see practice changing highlights from #ISTH2025, you can check out the VLN Newsletter vln.thrombosis.org/c/clinical-r... or log in to the VLN ISTH 2025 Community Page lnkd.in/eyrrr4qZ to see ALL the posts and interact with the community. I look forward to seeing you there!vln.thrombosis.orgISTH 2025 Congress Highlights: What You Might Have Missed | Vasculearn NetworkKey Insights from our Board members, @Alfonso J Tafur and @Tara K. Lech Log in to https://vln.thrombosis.org and check out the ISTH 2025 Community Page for more details & even more presentations not... 133
Reposted by Tara Lech, PharmDShematologist, MD @shematologist.medsky.social · 10/05/2025Vasculearn Network is hosting a Women's Health Support Group May 12th @ 7PM EST This is a safe & trusted space for patients to ask questions, receive educational resources & feel supported as they learn to VascuLive with their diagnosis 👉Register lnkd.in/esHHKW62lnkd.inLinkedInThis link will take you to a page that’s not on LinkedIn 2227
Tara Lech, PharmD @anticoagpharmd.bsky.social · 08/04/2025Did you know that NATF has rebranded? Check out the brand new Vasculearn Network: www.google.com/url?q=https:... Their dynamic site is full of great resources for patients & providers. I personally love their patient support groups and reading What’s Hot in Clots by @bbikdeli.bsky.social!google.comRedirecting 021
Tara Lech, PharmD @anticoagpharmd.bsky.social · 08/04/2025Outpatient management of CAT? Insightful review from @marccarriermd.bsky.social @drdebthrombo.bsky.social & colleagues publications.ersnet.org/content/erj/...publications.ersnet.orgOutpatient management of cancer-associated pulmonary embolism: a systematic review and meta-analysisGraphical abstracterj;65/4/2401596/GA1F1GA1Overview of the study. (s)PESI: (simplified) Pulmonary Embolism Severity Index; VTE: venous thromboembolism. 030
Reposted by Tara Lech, PharmDBethany Samuelson Bannow, MD, MCR (she/her) @btsamuelsonmd.bsky.social · 26/03/2025Excited to share an important new document from ACForum and FWGBD addressing the care of folks with the potential to menstruate (or enter menopause!) or become pregnant. Check it out! acforum.org/web/resource...acforum.org 121
Tara Lech, PharmD @anticoagpharmd.bsky.social · 11/03/2025📢 Calling all Anticoagulation Specialists! Come join our comprehenisve management program. We care for patients on warfarin & DOACs with an emphasis on #Stewardship #Quality and #Equity Please reach out with any questions #jobs #hiring #pharmsky #skyrx #anticoagualtion jobs.bilh.org/job/cambridg...jobs.bilh.orgClinical Pharmacist Specialist Anticoagulation Hybrid / Remote (Burlington, MA.) at Beth Israel Lahey HealthLearn more about applying for Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote (Burlington, MA.) at Beth Israel Lahey Health. 010
Reposted by Tara Lech, PharmDGeoffrey Barnes, MD, MSc @gbarnesmd.bsky.social · 25/01/2025The @medscape.com Heart of Cardiology 2025 conference started yesterday with several stellar presentations! Here are a few key take away points that I’ve been thinking about… www.heartofcardio.com/agendaheartofcardio.comAgendaOur comprehensive agenda will cover Cardiometabolic Health, Cardiovascular Prevention, Atherosclerosis, Thrombosis, Cardiovascular Dysfunction, Arrhythmias, Valvular Heart Disease and more. 364
Tara Lech, PharmD @anticoagpharmd.bsky.social · 14/01/2025Ok, here is the big lesson learned: 💡 When setting up the transfer device the Balfaxar vial MUST be on a solid flat surface so you can push down with force - We observed team members just connecting the 2 vials, and this led to a loss in the seal & increased transfer times #pharmRx #SkyRx #PharmSky 141
Tara Lech, PharmD @anticoagpharmd.bsky.social · 09/01/2025💡In this study, < 25% of pts with a major bleed had documented discussions about LAAO & > 25% permanently 🚫 anticoag. Education & shared decision making is vital. These pt are still at risk for embolic events pubmed.ncbi.nlm.nih.gov/39644619/?ut... @gbarnesmd.bsky.socialpubmed.ncbi.nlm.nih.govPrevalence of discussions around left atrial appendage occlusion as a treatment option in patients on oral anticoagulation experiencing a major bleeding event - PubMedIn patients experiencing a major bleed, less than a quarter had documented discussions about LAAO and over a quarter permanently stopped anticoagulation. 011
Tara Lech, PharmD @anticoagpharmd.bsky.social · 09/01/2025I am a big fan of practicle papers! It is great to see how providers are handling these interactions and what the impact on patient outcomes #PharmRx #Skypharm #Hemesky #MedSky pubmed.ncbi.nlm.nih.gov/39643974/pubmed.ncbi.nlm.nih.govDrug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding...Drug-drug interactions between direct oral anticoagulants and anticancer drugs: A single center daily practice evaluation of the occurrence, prescriber response, and subsequent thrombotic and bleeding... 000
Tara Lech, PharmD @anticoagpharmd.bsky.social · 23/12/2024Is anyone routinely checking DOAC levels and changing therapy as a result? Curious to see what others are doing in practice #SkyRx #PharmSky #MedSky pubmed.ncbi.nlm.nih.gov/38884944/pubmed.ncbi.nlm.nih.govA Pilot Study Describing DOAC Level Results and Association With Clinical Outcomes - PubMed<span><b>Purpose:</b> Describe direct oral anticoagulant (DOAC) level ordering and interpretation practices in association with clinical outcomes at a vascular medicine clinic. <b>Methods:</b> This st... 110
Tara Lech, PharmD @anticoagpharmd.bsky.social · 20/12/2024🚨 Help needed! We recently switched to Balfaxar and are having issues with reconstitution. Any tips or tricks? Nurses are reporting times > 10min which is not ideal. Thanks! #PharmRx #SkyRx #PharmSky #MedSky #HemeSky #CardioSky 141
Tara Lech, PharmD @anticoagpharmd.bsky.social · 18/12/2024👀 🚨 FDA denies full approval of Andexanet Can’t say I am surprised. It will be interesting to see what happens next #SkyRx #PharmSky #CardioSky #HemeSky firstwordpharma.com/story/5921956firstwordpharma.comFirstWord 0107
Tara Lech, PharmD @anticoagpharmd.bsky.social · 27/11/2024💡Great for trainees! #AnticoagStewardship #CardioSky #MedSky #PharmSky #SkyRx @bbikdeli.bsky.social pubmed.ncbi.nlm.nih.gov/39557062/pubmed.ncbi.nlm.nih.govDirect Oral Anticoagulants: Quick Primer on When to Use and When to Avoid - PubMedDirect oral anticoagulants (DOACs) have transformed the landscape of antithrombotic therapy in the past two decades. However, there is uncertainty about when they should or should not be used for trea... 2124
Tara Lech, PharmD @anticoagpharmd.bsky.social · 27/11/2024🌟 Good read on how to apply the CHADSVaSc score in clinical practice @gbarnesmd.bsky.social & #GregoryLip #CardioSky #PharmSky #SkyRx #Afib #AnticoagStewardship pubmed.ncbi.nlm.nih.gov/39365222/pubmed.ncbi.nlm.nih.govApplying Clinical Risk Scores in Real-World Practice: The CHA2DS2-VASc Score in Atrial Fibrillation - PubMedApplying Clinical Risk Scores in Real-World Practice: The CHA2DS2-VASc Score in Atrial Fibrillation 040
Reposted by Tara Lech, PharmDBethany Samuelson Bannow, MD, MCR (she/her) @btsamuelsonmd.bsky.social · 26/11/2024We *tried* to do a meta-analysis on menstrual bleeding in FXI inhibitor studies - not only is it not an outcome, but hardly any participants were capable of menstruation. We call for action to improve capture of HMB in anticoagulant trials in our latest @jthjournal.bsky.social pub. t.co/c26Y0umzOit.cohttps://authors.elsevier.com/a/1k6ci5TuFxIuhI 095
Tara Lech, PharmD @anticoagpharmd.bsky.social · 26/11/2024🚨 Great teaching article 💡Review of cancer therapies that ⬆️ risk of arrhythmias (Did you know Ibrutinib ⬆️ AF risk by 15 fold 🤯) 💡Rate control typically preferred 💡AC can be challenging in frail, pancytopenic, ⬆️🩸risk pts 💡👀 for DDIs 🌟Tailor therapy #CardioSky #SkyRx pubmed.ncbi.nlm.nih.gov/39551561/pubmed.ncbi.nlm.nih.govArrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation - PubMedCardiovascular disease and cancer are the leading cause of mortality in the United States. In 2021, there were 695,547 and 605,213 deaths due to heart disease and cancer, respectively. With novel onco... 041
Tara Lech, PharmD @anticoagpharmd.bsky.social · 20/11/2024Are your patients looking for a safe space to ask questions & receive accurate information about their blood clots? The Vasculearn Network, offers free monthly virtual support groups for patients with blood clots. Along with focused sessions for: -Long PE/CTEPH -Cancer -Women’s Health #HemeSky 010
Reposted by Tara Lech, PharmDShematologist, MD @shematologist.medsky.social · 15/11/2024The CDC and WHO report a 20% increase in measles cases last year, driven by decreases in vaccination. This equated to 107,500 DEATHS, mostly in young children. This, in a PREVENTABLE disease. Can only imagine what that number will be if we get rid of all mandates. 541176423
Tara Lech, PharmD @anticoagpharmd.bsky.social · 15/11/2024🔊 Recording now available for the #ACForum "Ask the Experts" webinar! Watch here: bit.ly/3QLuunC Expert insights & Q&A session on: 🔹Thrombosis & Thrombophilia 🔹Valvular Disease & Anticoag 🔹Women's Health 🔹Inpatient Anticoag & Acute Care Management 🔹Outpatient Care #AnticoagStewardship 010
Tara Lech, PharmD @anticoagpharmd.bsky.social · 14/11/2024🌟Come Join Our Team🌟 🌟2 New Positions, remote/hyrbid🌟 We are looking for skilled Anticoag Pharmacists to grow our Stewardship program. This role will focus on CDTM based outpt mgmt of antithrombotic therapy #AnticoagStewardship #jobs #pharmacist jobs.bilh.org/job/burlingt...jobs.bilh.orgClinical Pharmacist Specialist Anticoagulation Hybrid / Remote at Beth Israel Lahey HealthLearn more about applying for Clinical Pharmacist Specialist Anticoagulation Hybrid / Remote at Beth Israel Lahey Health. 164
Tara Lech, PharmD @anticoagpharmd.bsky.social · 12/11/2024💡Check out the BLEED study 🩸🩸 Woman on #Anticoagulation are at risk for ABNORMAL Uterine Bleeding It is important to understand the risk, proactively counsel, provide f/u & screening, and treat when indicated. Women don’t need to suffer 🫶🏼 #AnticoagStewardship pubmed.ncbi.nlm.nih.gov/39505000/pubmed.ncbi.nlm.nih.govBlood Loss in Women of Childbearing Potential Taking Oral Anticoagulants for Venous Thromboembolism (The BLEED Study) - PubMedOral anticoagulants (OAC) may exacerbate menstrual bleeding in women of childbearing age; however, the existing literature on this issue has several limitations. This study investigates abnormal uteri... 0249
Tara Lech, PharmD @anticoagpharmd.bsky.social · 11/11/2024Excited to be a part of this amazing panel! It should be an excellent discussion! Hope to see you there 👀🫶🏼 031
Tara Lech, PharmD @anticoagpharmd.bsky.social · 11/11/2024Good Morning! Hoping to fine a new community to learn from and share information ✨ About me: Pharmacist x 18yrs Focus: Antithrombotic Management with an emphasis on #Stewardship Other Interests: 🧘🏻♀️, 🥾🏔️🚵♂️, 📖, TS🫶🏼 #MedSky #SkyRX #PharmSky 171